A Virologist Explains: mRNA Coronavirus Vaccines And What Investors Should KnowThe Motley Fool • 11/19/20
French drugmaker Sanofi has just invested $59 million in biotech investor Jeito Capital to fund innovation in the biopharma pipelineBusiness Insider • 11/13/20
These Red-Hot Biotechs Are Leading The Pack And Could Be ActionableInvestors Business Daily • 11/10/20
Sanofi's factory of the future named world's best overall facility by International Society for Pharmaceutical EngineeringPRNewsWire • 11/03/20
15 High-Yield/Low Volatility Blue Chips For The Ultimate Crash-Proof Retirement PortfolioSeeking Alpha • 11/02/20
Sanofi offers to acquire Kiadis, a clinical-stage company developing cell-based immunotherapy productsGlobeNewsWire • 11/02/20
European Patent Office rules in favor of Sanofi and Regeneron concerning Praluent® (alirocumab)GlobeNewsWire • 10/29/20
Sanofi to evaluate the safety and efficacy of novel investigational candidate THOR-707 and KEYTRUDA® (pembrolizumab) in pursuit of establishing a new treatment option in oncologyGlobeNewsWire • 10/29/20
Sanofi, GSK to provide 200 million Covid vaccine doses to WHO global immunization programCNBC • 10/28/20